Robert Cascella Neuronetics, Inc. (STIM) insider trading activity

Robert Cascella is of Neuronetics, Inc.. Currently has a direct ownership of 453,098 shares of STIM, which is worth approximately $629,806. The most recent transaction as insider was on Sep 12, 2024, when has been sold 100,000 shares (Common Stock) at a price of $0.75 per share, resulting in proceeds of $75,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 453K

0% 3M change

178.23% 12M change

Total Value Held $629,806

ROBERT CASCELLA Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 12 2024	BUY Open market or private purchase	$75,000 $0.75 p/Share	100,000 Added 18.08%	453,098 Common Stock
Aug 19 2024	BUY Open market or private purchase	$4,560 $1.14 p/Share	4,000 Added 1.12%	353,098 Common Stock
Aug 16 2024	BUY Open market or private purchase	$37,100 $1.06 p/Share	35,000 Added 9.11%	349,098 Common Stock
Aug 15 2024	BUY Open market or private purchase	$30,800 $0.88 p/Share	35,000 Added 10.03%	314,098 Common Stock
Aug 14 2024	BUY Open market or private purchase	$27,650 $0.79 p/Share	35,000 Added 11.14%	279,098 Common Stock
Jun 06 2024	BUY Open market or private purchase	$102,499 $2.05 p/Share	50,000 Added 17.0%	244,098 Common Stock
May 30 2024	BUY Grant, award, or other acquisition	-	31,250 Added 13.87%	194,098 Common Stock
Aug 10 2023	BUY Grant, award, or other acquisition	$51,585 $1.81 p/Share	28,500 Added 14.89%	162,848 Common Stock
May 25 2023	BUY Grant, award, or other acquisition	-	45,455 Added 25.28%	134,348 Common Stock
May 26 2022	BUY Grant, award, or other acquisition	-	48,638 Added 35.37%	88,893 Common Stock
Nov 22 2021	BUY Open market or private purchase	$61,500 $4.1 p/Share	15,000 Added 27.15%	40,255 Common Stock
Aug 30 2021	BUY Open market or private purchase	$100,800 $6.72 p/Share	15,000 Added 37.26%	25,255 Common Stock
May 27 2021	BUY Grant, award, or other acquisition	-	8,922 Added 46.52%	10,255 Common Stock
Apr 01 2021	BUY Grant, award, or other acquisition	-	1,333 Added 50.0%	1,333 Common Stock

Also insider at

MIR

Mirion Technologies, Inc. Industrials

Director

KRMD

KORU Medical Systems, Inc. Healthcare

Director

Robert Cascella

Mahwah, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STIM shares.

Notify only if

Value

Insider Trading

Get notified when an Neuronetics, Inc. insider buys or sells STIM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Neuronetics, Inc.

Track Activities on STIM

Account